ArticleContemporary clinical trials communications2023

NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trial.

Muhammad Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.